Literature DB >> 25043759

American Society of Peritoneal Surface Malignancies opinion statement on defining expectations from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer.

Jesus Esquivel1, Pompiliu Piso, Vic Verwaal, Thomas Bachleitner-Hofmann, Olivier Glehen, Santiago González-Moreno, Marcello Deraco, Joerg Pelz, Richard Alexander, Gabriel Glockzin.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25043759     DOI： 10.1002/jso.23722

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


× No keyword cloud information.
  15 in total

Review 1.  Palliative cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion: current clinical practice or misnomer?

Authors:  Laura A Lambert; Ariana Harris
Journal:  J Gastrointest Oncol       Date:  2016-02

2.  Laparoscopy as a useful selection tool for patients with prior surgery and peritoneal metastases suitable for multimodality treatment strategies.

Authors:  Philipp von Breitenbuch; Thomas Boerner; Tonia Jeiter; Pompiliu Piso; Hans J Schlitt
Journal:  Surg Endosc       Date:  2017-12-07       Impact factor: 4.584

Review 3.  Metastatic Colorectal Cancer to the Peritoneum: Current Treatment Options.

Authors:  Nikolaos Vassos; Pompiliu Piso
Journal:  Curr Treat Options Oncol       Date:  2018-09-01

4.  Quality Standards for Surgery of Colorectal Peritoneal Metastasis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Authors:  Alfonso García-Fadrique; Rafael Estevan Estevan; Luis Sabater Ortí
Journal:  Ann Surg Oncol       Date:  2021-08-25       Impact factor: 5.344

Review 5.  Surgical technology and pharmacology of hyperthermic perioperative chemotherapy.

Authors:  Paul H Sugarbaker; Kurt Van der Speeten
Journal:  J Gastrointest Oncol       Date:  2016-02

6.  Outcome of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Colorectal Cancer.

Authors:  Danilo Coco; Silvana Leanza
Journal:  Maedica (Buchar)       Date:  2019-09

7.  PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 Trial.

Authors:  Mustafa Raoof; Gautam Malhotra; Adrian Kohut; Michael O'Leary; Paul Frankel; Thuy Tran; Marwan Fakih; Joseph Chao; Dean Lim; Yanghee Woo; Isaac B Paz; Michael Lew; Mihaela C Cristea; Lorna Rodriguez-Rodriguez; Yuman Fong; Andrew Blakely; Richard Whelan; Marc A Reymond; Amit Merchea; Thanh H Dellinger
Journal:  Ann Surg Oncol       Date:  2021-08-13       Impact factor: 5.344

8.  Serum CA125 concentration as a predictor of peritoneal dissemination of colorectal cancer in men and women.

Authors:  Chi-Jung Huang; Jeng-Kai Jiang; Shih-Ching Chang; Jen-Kou Lin; Shung-Haur Yang
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

Review 9.  A multidisciplinary approach for peritoneal carcinomatosis and bilobar liver metastases from colorectal cancer: case report and review of the literature.

Authors:  César P Ramírez-Plaza; Francisco J Moreno-Ruiz; José A Pérez-Daga
Journal:  World J Surg Oncol       Date:  2015-08-01       Impact factor: 2.754

10.  Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal cancer: 2-year follow-up results at a single institution in Korea.

Authors:  Min Hyeong Jo; Jung Wook Suh; Jeong Seok Yun; Hwan Namgung; Dong-Guk Park
Journal:  Ann Surg Treat Res       Date:  2016-09-30       Impact factor: 1.859
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.